Study of gut bacteria and immune changes in colon tissue
Part of Cancer, Digestive system clinical trials.
This study looks at how gut bacteria and immune activity differ in normal, pre-cancer, and cancer colon tissue. It may help researchers understand what changes in the body are linked to colon growth and how they could be targeted in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to understand and sign consent.
- You must have a colorectal lesion (benign or cancer stages I–III) or localized colon/rectum cancer going to surgery.
- If you had antibiotics, it must be at least 8 weeks ago, and if you had certain immune-changing medicines (like steroids or immune suppressors), it must be at least 4 weeks ago.
- You must be willing and able to follow the study procedures.
- You must have medical insurance coverage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying patients with colorectal cancer who are scheduled for surgery. Researchers want to learn more about the cancer to improve future treatments.
This study looks at how bacteria in your gut, your immune system, and colon cancer interact. It aims to understand these connections to improve future treatments.
This study collects tissue and blood samples from people with colorectal, pancreatic, or bile duct cancer to learn how the immune system reacts to these tumors. The goal is to better understand cancer biology and potentially improve future treatments.
This study mainly watches and records health information from adults with colorectal cancer (or a strong suspicion of it). It collects past tumor tissue and other clinical details to better understand the disease and care.
This trial looks at how your immune cells change before and after surgery for colorectal cancer, and whether those changes affect your long-term recovery. It may help doctors predict outcomes and improve care.
This study looks at how the immune system around a colorectal tumor relates to resistance to chemotherapy. You may be able to join if you are having surgery soon for colorectal cancer and have not yet had chemotherapy before surgery.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.